Concord Biotech Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
4 Jun 20241575773 Ontario Inc
Reg29(2)
Sale Open Market — 3,548,211
3.39%
2.00% No
31 Aug 2023Estate of Late Mr. Rakesh Jhunjhunwala along with pac
Reg29(1)
Acquisition Others 0
0.00%
— 24.80% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.